News

The Pharma Letter21h
Reshaping HIV – how the journey from daily pills to long-acting therapies could take us closer to ending the HIV epidemic
Dr Kimberly Smith, Senior Vice President, Chief Scientific Officer, Head of Research & Development at ViiV Healthcare, ...
The Pharma Letter23h
Verastem expands ambitions with strong pancreatic cancer data at ASCO
Verastem Oncology has unveiled updated early-stage data from its RAMP 205 trial in metastatic pancreatic cancer, bolstering ...
The Pharma Letter23h
Ionis’ olezarsen shows new promise with strong Phase III results
US biotech Ionis Pharmaceuticals has reported positive top-line data from the Phase III ESSENCE trial of its antisense drug ...